参考文献/References:
[1] 陈晓芳, 陈万青, 周薇薇, 等.2013 年中国膀胱癌发
病和死亡流行状况分析[J]. 中国肿瘤,2018,27(2):81-
85.CHEN Xiaofang,CHEN Wanqing, ZHOU Weiwei,et al.
Analysis of incidence and mortality of bladder cancer
in China, 2013 [J]. China Cancer, 2018,27(2): 81-85.
[2] 时景伟, 孔庆阔, 陈晓亮, 等. 膀胱肿瘤抗原、尿脱
落细胞学、泌尿系彩超联合检查在膀胱癌诊断中的
价值[J]. 中华实验外科杂志,2018,35(12):2346-2347.
SHI Jingwei,KONG Qingkuo,CHEN Xiaoliang,et
al. Clinical value of combined use of urine bladder
tumor antigen stat test, transa blominal ultrasonography
and urinary cytology in diagnosis of bladder
cancer[J]. Chinese Journal of Experimental Surgery,
2018,35(12):2346-2347.
[3] 孙福振, 杨涛, 王刚, 等. 尿膀胱肿瘤抗原测定在膀
胱癌术后复发监测中的应用[J]. 中国老年保健医
学,2018,16(5):47-48.
SUN Fuzhen,YANG Tao,WANG Gang,et a l .
Application of urinary bladder tumor antigen detection
in the monitoring of postoperative recurrence of bladder
carcinoma[J]. Chinese Journal of Geriatrics Care,
2018,16(5):47-48.
[4] 郭毓鹏, 关红军, 董晶, 等. 尿膀胱癌抗原检测诊
断膀胱癌的Meta 分析[J]. 临床泌尿外科杂志,
2015,30(5): 420-424.
GUO Yupeng,GUAN Hongjun,DONG Jing,et al.
Urinary bladder cancer test in the diagnosis of
bladder cancer: a meta analysis[J]. Journal of clinical
urology,2015,30(5): 420-424.
[5] CHANG T C, MARCQ G, KISS B, et al. Imageguided
transurethral resection of bladder tumorscurrent
practice and future outlooks[J]. Bladder Cancer,
2017,3(3): 149-159.
[6] D’COSTA J J, GOLDSMITH J C, WILSON J S, et al.
A systematic review of the diagnostic and prognostic
value of urinary protein biomarkers in urothelial
bladder cancer[J]. Bladder Cancer, 2016, 2(3): 301-317.
[7] MUHAMMAD A S, MUNGADI I A, DARLINGTON
N N, et al. Effectiveness of bladder tumor antigen
quantitative test in the diagnosis of bladder carcinoma
in a schistosoma endemic area, UrolAnn[J].
2019,11(2):143-148.
[8] CHOU R, GORE J L, BUCKLEY D ,et al.Urinary biomarkers
for diagnosis of bladder cancer: A systematic
review and meta-analysis[J]. Ann Intern Med.
2015,163(12):922-931.
[9] 薛玉泉, 王振龙, 张亚平, 等. 尿膀胱肿瘤抗原在膀
胱癌诊断中的临床价值及相关性分析[J]. 癌症进
展,2019,17(1):45-48.
XUE Yuquan,WANG Zhenlong, ZHANG Yaping, et
al. The clinical significance and influencing factors
of urinary bladder tumor antigen in the diagnosis of
bladder cancer[J]. Oncolgy Progress,2019,17(1):45-48.
[10] GUO Aiye, WANGXiuhua, GAO Lan, et al.Bladdertumour
antigen (BTAstat) test compared to the urine cytology in
the diagnosis of bladder cancer:a meta analysis[J].Can
Urol Assoc J,2014, 8(5/6):E47-E52.
相似文献/References:
[1]谢小娟,朱 娜,潘晶晶,等.miRNA-148a在膀胱癌组织中的表达及生物信息学分析[J].现代检验医学杂志,2015,30(04):6.[doi:10.3969/j.issn.1671-7414.2015.04.002]
XIE Xiao-juan,ZHU Na,PAN Jing-jing,et al.Expression of miRNA-148a in Bladder Carcinoma Tissues
and Its Bioinformatics Analysis[J].Journal of Modern Laboratory Medicine,2015,30(06):6.[doi:10.3969/j.issn.1671-7414.2015.04.002]
[2]郎海雷,曹雷涛,贵英斌,等.LncRNA NNT-AS1 通过调控miR-582-5p/NCKAP1 轴激活Hippo-YAP/TAZ 信号通路促进膀胱癌细胞增殖、迁移、侵袭和干细胞干性影响[J].现代检验医学杂志,2023,38(04):27.[doi:10.3969/j.issn.1671-7414.2023.04.005]
LANG Hailei,CAO Leitao,GUI Yingbin,et al.LncRNA NNT-AS1 Activates Hippo-YAP/TAZ Signaling Pathway by Regulating miR-582-5p/NCKAP1 Axis to Promote Bladder Cancer Cell Proliferation, Migration, Invasion and Stem Cell Stemness Effects[J].Journal of Modern Laboratory Medicine,2023,38(06):27.[doi:10.3969/j.issn.1671-7414.2023.04.005]
[3]梅 竹,任 赛,唐思恬,等.膀胱癌患者尿液外泌体中miR-494-3p，LncRNA MAGI2-AS3 表达水平及临床价值研究[J].现代检验医学杂志,2024,39(04):5.[doi:10.3969/j.issn.1671-7414.2024.04.002]
MEI Zhu,REN Sai,TANG Sitian,et al.Study on Expression Levels and Clinical Value of miR-494-3p and LncRNA MAGI2-AS3 in Urine Exosomes of Patients with Bladder Cancer[J].Journal of Modern Laboratory Medicine,2024,39(06):5.[doi:10.3969/j.issn.1671-7414.2024.04.002]